Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets, covering 2019-02-19 to 2019-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment [Phase 2]